Skip to main content
. 2014 Oct 17;7(12):1365–1378. doi: 10.1242/dmm.017137

Fig. 3.

Fig. 3.

Loss of dGALT activity compromises the NMJ glycosylated synaptomatrix. Representative wandering L3 NMJs imaged with anti-Fasciclin-II (FASII; red) in all cases and co-labeled with lectins (A) Erythrina cristagalli (ECL; green), (B) Wisteria floribunda (WFA; green) and (C) anti-horseradish-peroxidase (HRP; green) in genetic controls (precise-excision dGALTC2) and dGALT nulls (imprecise-excision dGALTΔAP2). Quantification shows normalized ECL (≥15 NMJs) (A′), WFA (≥19 NMJs) (B′) and anti-HRP (≥16 NMJs) (C′) intensities. Error bars show s.e.m. with significance indicated as **P<0.01.